"Insulin-Secreting Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of pancreatic cell representing about 50-80% of the islet cells. Beta cells secrete INSULIN.
| Descriptor ID |
D050417
|
| MeSH Number(s) |
A03.734.414.131 A06.390.131 A06.407.414.087 A11.382.625.092 A11.436.294.092
|
| Concept/Terms |
Insulin-Secreting Cells- Insulin-Secreting Cells
- Cell, Insulin-Secreting
- Cells, Insulin-Secreting
- Insulin Secreting Cells
- Insulin-Secreting Cell
- beta Cells, Pancreatic
- Pancreatic beta Cell
- beta Cell, Pancreatic
- Pancreatic B Cells
- B Cell, Pancreatic
- B Cells, Pancreatic
- Pancreatic B Cell
- Pancreatic beta Cells
|
Below are MeSH descriptors whose meaning is more general than "Insulin-Secreting Cells".
Below are MeSH descriptors whose meaning is more specific than "Insulin-Secreting Cells".
This graph shows the total number of publications written about "Insulin-Secreting Cells" by people in this website by year, and whether "Insulin-Secreting Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 5 | 2 | 7 |
| 2006 | 10 | 2 | 12 |
| 2007 | 10 | 2 | 12 |
| 2008 | 12 | 4 | 16 |
| 2009 | 17 | 7 | 24 |
| 2010 | 17 | 4 | 21 |
| 2011 | 14 | 2 | 16 |
| 2012 | 20 | 4 | 24 |
| 2013 | 14 | 3 | 17 |
| 2014 | 14 | 2 | 16 |
| 2015 | 17 | 5 | 22 |
| 2016 | 8 | 6 | 14 |
| 2017 | 12 | 2 | 14 |
| 2018 | 14 | 5 | 19 |
| 2019 | 8 | 3 | 11 |
| 2020 | 6 | 5 | 11 |
| 2021 | 8 | 1 | 9 |
| 2022 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin-Secreting Cells" by people in Profiles.
-
Palmitoylation couples insulin hypersecretion with ? cell failure in diabetes. Cell Metab. 2023 02 07; 35(2):332-344.e7.
-
Inside the ? Cell: Molecular Stress Response Pathways in Diabetes Pathogenesis. Endocrinology. 2022 11 14; 164(1).
-
MYCL-mediated reprogramming expands pancreatic insulin-producing cells. Nat Metab. 2022 02; 4(2):254-268.
-
Stem Cell Educator therapy in type 1 diabetes: From the bench to clinical trials. Autoimmun Rev. 2022 May; 21(5):103058.
-
Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic ?-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries. Mol Metab. 2022 01; 55:101392.
-
Identification of direct transcriptional targets of NFATC2 that promote ? cell proliferation. J Clin Invest. 2021 11 01; 131(21).
-
Dietary Selenium Deficiency Partially Mimics the Metabolic Effects of Arsenic. Nutrients. 2021 Aug 23; 13(8).
-
Dynamin deficiency causes insulin secretion failure and hyperglycemia. Proc Natl Acad Sci U S A. 2021 08 10; 118(32).
-
12-Lipoxygenase governs the innate immune pathogenesis of islet inflammation and autoimmune diabetes. JCI Insight. 2021 07 22; 6(14).
-
?-Cell pre-mir-21 induces dysfunction and loss of cellular identity by targeting transforming growth factor beta 2 (Tgfb2) and Smad family member 2 (Smad2) mRNAs. Mol Metab. 2021 11; 53:101289.